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The pomegranate, Punica granatum L., which can be found throughout the Mediterranean region, in 
Southeast Asia, California and Arizona in USA was in ancient times referred as possessing powers of 
fertility, abundance and good luck (fruit). The biological properties of extracts (antimicrobial, 
antioxidant, anticancer, anti-inflammatory, among other properties) obtained from several parts of 
pomegranate is reported in the present work. Due to such properties, the extracts have been used in 
therapeutics, such as in the prevention of infection, inflammation, cancer, among other applications. 
However, other aspects are also referred in the present work such as the good practices of culture and 
fruit preservation, search of new compounds, selection of cultivars through biotechnological 
techniques for obtaining juice or fruits ready to eat. Such compilation of information was based on the 
search in the ISI Web of Knowledge (Thomson Reuters) from 2009 up to the beginning of October 2010. 
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INTRODUCTION 
 
Phytotherapy is considered as a complementary 
approach for preventing and treating simple disease, 
although well grounded in medical tradition, it often lacks 
proper scientific validation (Cravatto et al., 2010). These 
authors focused the search on clinical investigations 
concerning some plants, including Punica granatum L. 
(pomegranate). In addition to the its ancient historical 
uses (it was lauded in the Old Testament of the Bible, 
Koran, the Jewish Torah, and the Babylonian Talmud as 
a sacred fruit  conferring  powers  of  fertility,  abundance, 
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and good luck) pomegranate is used in diverse systems 
of medicine as ailments. According to the review article 
made by Julie (2008) about the therapeutic applications 
of pomegranate, the author refers that in Ayurvedic 
medicine, the pomegranate is used as antiparasitic 
agent, a blood tonic, and to heal aphtae, diarrhoea and 
ulcers. In the Unani system, practiced in the Middle East  
and India, and according to the same review, 
pomegranate was described also a remedy for diabetes 
(Julie, 2008). 
The edible part of the fruits contains acids, sugars, 
vitamins, polysaccharides, polyphenols and minerals, 
however, several factors may contribute to the chemical 
changes, including cultivars, environmental conditions, 
ripening, storage and postharvest treatments, which  may 
  
 
 
affect fruit quality and health beneficial compounds 
(Schwartz et al., 2009a). 
A recent review reported the chemical constituents of 
diverse parts of P. granatum as well as their potential for 
prevention and treatment of inflammation and cancer. 
The authors refer that in pericarp, leaf and flower can be 
detected phenols (flavonoids and tannins) being some of 
them unique. Complex polysaccharides have also been 
detected and characterized in the peels. In seeds, 
triacylglycerols constituted the oil, with a high content of 
punicic acid. In this oil, the authors also reported the 
presence of sterols, steroids and cerebroside in very 
small amounts. In addition to the seed oil, lignin and their  
derivatives have also been reported possessing 
remarkable antioxidant activities (Lansky and Newman, 
2007). In the same review article, the authors highlighted 
the major components of pomegranate seeds, juice, 
pericarp, bark and leaf as well as their pharmacological 
activity in mammalian cells relevant to the prevention 
and/or treatment of malignant cell growth, from 2000 to 
2006. The mechanisms claimed by the authors referred 
in that review article included increased apoptosis, 
decreased inflammation, decreased metastasis and 
invasion, as well as a decrease in drug resistance 
(Lansky and Newman, 2007). Antixodiant activities 
associated with different pomegranate components were 
also summarized by the authors. 
One year later, other review article (Julie, 2008) 
revealed that pomegranate juice may be fruitful as a 
therapy for prostate cancer, particularly recurrent type of 
cells; in atherosclerosis by inhibiting the lipid peroxidation 
in plasma and in lipoproteins as well as the collagen-
induced platelet aggregation in human platelets ex vivo; 
in hyperlipidemia owing to the decrease absorption and 
increased faecal excretion of cholesterol as well as 
possible effects on HMG-CoA reductase and sterol O-
acyltransferase, two enzymes key to cholesterol 
metabolism. Pomegranate juice was also reported 
effective in hypertension by decreasing Angiotensin-
Converting Enzyme (ACE) activity; reducing myocardial 
ischemia and improving myocardial perfusion; in diabetes 
through a significant effect on atherogenesis through 
reduced oxidative stress; in periodontal disease and 
denture stomatitis. Other benefits include the combat to 
some bacterial infections, erectile dysfunction, male 
infertility, Alzheimer’s disease, obesity. The authors also 
refer those works concerning the pharmacokinetic 
(metabolism and availability) of ellagitannins present in 
pomegranate juice as well as the potential drug 
interactions and safety of pomegranate extracts. 
As a crop, pomegranate is extensively cultivated in 
Iran, India, Afghanistan and Mediterranean countries, and  
to some extent in the USA, China, Japan and Russia 
(Narzary et al., 2010a). It is one of the most valuable 
fruits and is grown on a commercial scale also in Iran 
(Ramezanian et al., 2009). Pomegranate fruit is 
consumed directly as fresh seeds, but can  also  be  used 
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for making juice, jelly, grenadine or as flavouring and 
colouring agents. In addition, this species has been 
proved to possess therapeutic properties, therefore with 
an economical and ecological importance (Al-Said et al., 
2009; Akbarpour et al., 2010). 
The last review about the therapeutic effects of 
pomegranate found in the ISI Web of Knowledge 
(Thomson Reuters) was that of Julie (2008). Therefore, 
the present work intends to make a review about this 
subject using the same database from 2009 up to 3rd 
October, 2010. Search keys used for the research were: 
P. granatum (topic) and 2009 to 2010 (year published). 
Over 200 works were found including abstracts, 
proceedings, articles and patents. In some few cases 
references other than 2009 to 2010 can be cited only as 
introductory to the more recent works. 
The predominant theme was indubitably the biological 
properties of pomegranate, nevertheless other 
approaches were also found: pests and diseases in 
pomegranate crop (Bardas et al., 2009; Mondal and 
Mani, 2009; Qasen, 2009; Spadaro et al., 2010; 
Wohlfarter et al., 2010a; Wohlfarter et al., 2010b); 
pomegranate on the combat of microorganisms affecting 
plants (Guo et al., 2009; Hassan et al., 2009; Tayel et al., 
2009a; Osorio et al., 2010), seeds during storage 
(Gandhi et al., 2010) or against Lymphocystis Disease 
Virus (LDV) in the fish olive flounder Paralichthys 
olivaceus (Harikrishnan et al., 2010). Other themes could 
also been found such as methods, analysis of several 
compounds from pomegranate and influence of some 
factors such as cultivar, fruit development on the 
chemical composition (Al-Said et al., 2009; Kýralan et al., 
2009; Liu et al., 2009; Martin et al., 2009; Sassano et al., 
2009; Schwartz et al., 2009b; Zhang et al., 2009; 
Akbarpour et al., 2010; Caligiani et al., 2010; 
Panichayupakaranant et al., 2010; Qu et al., 2010). New 
compounds found for the first time in P. granatum were 
also reported (Bagri et al., 2009a; Bonzanini et al., 2009; 
Tantray et al., 2009; Bagri et al., 2010; Kho et al., 2010) 
as well as the physical properties of pomegranate (Celik 
and Ercisli, 2009). 
In technological terms, the development of new 
machines for the automatic sorting of pomegranate arils 
were also developed and reported by some authors 
(Blasco et al., 2009) as well as new drinks combining 
lemon and pomegranate juices (González-Molina et al., 
2009) or the powder of pomegranate as a natural textile 
dyestuff (Adeel et al., 2009).  
The appearance and quality of fresh fruits is a primary 
criterion in making purchasing decisions. Environment, 
agriculture conditions and postharvest treatments are 
fundamental for the acceptance of fruit by the consumers 
and several works reporting this theme could be found. 
Pomegranate is drought tolerant, winter hardy and can 
thrive well under desert conditions, frequently affected by 
high salinity, being proline considered as a possible 
drought stress indicator  in  pomegranate  fruits  (Halilova 
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and Yildiz, 2009). 
Studies regarding the selection of the most salinity-
resistant cultivar from Iran (Okhovatian-Ardakani et al., 
2010) or the effect of salt stress on the responses of 
evapotranspiration, crop coefficient and growth of 2 
varieties of pomegranate (P. granatum L. vars. 
‘Wonderful’ and ‘SP-2) irrigated with saline water were 
reported (Bhantana and Lazarovitch, 2010). Fertilization, 
including the use of biofertilizers, being one of the 
alternatives the use of nitrogen-fixing bacteria and 
arbuscular mycorrhizal fungi (Khanizadeh et al., 1995; 
Ghazi, 2006) have showed to contribute to the enhance 
of the growth and production of fruit plants significantly  
(Khorsandi and Yasdi, 2009; Khorsandi et al., 2009; 
Ramezanian et al., 2009). 
Other studies performed by Schwartz et al. (2009a) 
also demonstrated the importance of environmental 
conditions on the colour, taste and antioxidant capacity of 
11 pomegranate accessions’ fruits grown in 
Mediterranean and desert climates in Israel. The 
application of sunscreen is not novelty since Melgarejo et 
al. (2004) have already shown that the use of kaolin 
sunscreen treatments had reduced sunburn damage. 
Nevertheless, recent studies continue to develop new 
products for application as sunscreen of pomegranate 
fruits (Weerakkody et al., 2010). 
The effect of different scion-rootstock combinations on 
the vigour, tree size, yield and fruit quality of some 
Iranian commercial cultivars of pomegranate 
(Vazifeshenas et al., 2009), as well as the titratable 
acidity and the red colour parameters of this fruit were 
studied by some authors (Dafni-Yalin et al., 2010) for 
enabling breeders to select and breed genotypes having 
higher colour and desirable taste, and therefore helping 
industries to produce better pomegranate juices based on 
consume demand. 
Being pomegranate for fresh consumption of arils or 
juice, the appearance and colour of the skin of the fruit or 
juice and freshness are very crucial. Therefore, 
preservation and shelf-life extension have been the major 
goal of many works over time. Spermidine and calcium 
chloride (Ramezanian et al., 2010); polyamide plastic 
(Sadeghi and Akbarpour, 2009); individual film wrapping 
of pomegranate in combination with fludioxonil (D’Aquino 
et al., 2010) were all valuable treatments for improving 
storability of pomegranate fruits. 
Biotechnology has been the tool for characterize 
pomegranate cultivars. There are many molecular marker 
systems available to characterize genetic resources and 
cultivars (Staub et al., 1996). 
Randomly Amplified Polymorphic DNA (RAPD) 
markers and fruit traits were used by some authors 
(Zamani et al., 2010) for determining the molecular and 
pomological diversity among the popular pomegranate 
cultivar from the Eastern Mediterranean region of Turkey, 
respectively. 
On the other hand, Melgarejo et al. (2009)  evaluated  a 
 
 
 
 
genetic method to identify pomegranate cultivars. The 
procedure was based on the Restriction Fragment Length 
Polymorphisms (RFLP) and Polymerase Chain Reaction 
(PCR) techniques in 10 pomegranates accessions from 
the varietal groups ‘Mollar de Elche’, ‘Mollar de Albatera’, 
‘Mollar de Orihuela’, ‘Valencianas’ and ‘Bordes’. 
The studies performed by Narzary et al. (2009a) 
revealed that directed amplification of minisatellite DNA 
(DAMD) and RAPD profiles of wild pomegranates were 
able to characterize rapidly genotypes as well as DAMD 
revealed more polymorphism in comparison to RAPD. 
Inter Simple Sequence Repeat Profiles (ISSR) was 
used by Narzari et al. (2009b) in order to investigate the 
genetic diversity of natural pomegranate populations in 
India.  
Microsatellite-AFLP (M-AFLP) techniques were used by 
Curro et al. (2010) and Pirseyedi et al. (2010) in P. 
granatum. According to these authors, such markers 
reported for the first time should allow studies of the 
population structure and genetic diversity of pomegranate 
to be performed in the future. 
Other aspect in biotechnology on pomegranate is the 
regeneration of this plant by in vitro techniques. Kanwar 
et al. (2010) concluded that cotyledons excised from in 
vitro germinated seedlings were the most responsive 
explants for callus induction and plant regeneration. 
 
 
BIOLOGICAL PROPERTIES AND THERAPEUTIC 
APPLICATIONS 
 
A large number of articles concerning antimicrobial, 
antioxidant, anti-inflammatory, anticancer and immune-
suppressive activities of pomegranate in the period of 
2009 to 2010 (October) were found. Protective effects on 
hepatic function or on the glucose and lipid metabolism 
were also reported among other biological properties 
summarised below. 
 
 
Antimicrobial activity 
 
In the review article made by Julie (2008), the capacity of 
preventing infections of extracts of pomegranate was 
already well documented. Nevertheless, studies 
concerning this issue have continued. Food-borne 
illnesses are still a major concern for consumers, the food 
industry and food safety authorities. Therefore, works 
searching natural antimicrobials against these pathogens 
is a great goal of the scientists. Diverse extracts of 
pomegranate fruit peels, mainly 80% methanolic extract 
of peel revealed to be a potent inhibitor of Listeria 
monocytogenes, Staphylococcus aureus, Escherichia coli 
and Yersinia enterocolitica using both in vitro (agar 
diffusion) and in situ (food) methods. The authors 
attributed such activity to the presence of phenols since 
the   activity   of  the  samples  was  related  to  its  higher 
  
 
 
content in peels (Al-Zoreky, 2009). The combination of 
pomegranate juice and pomegranate polyphenols was 
also effective against food-borne viral infectivity. In the 
absence of culturable human noroviruses, feline 
calicivirus (FCV/F9), murine norovirus (MNV/1), and MS2 
(ssRNA) bacteriophage were used as foodborne viral 
surrogates. That combination was capable of causing 
reduction of foodborne viral surrogates FCV-F9, MNV-1 
and MS2 (especially on low titers). The authors 
concluded that these samples appear to be promising 
natural remedies for preventing or reducing human 
norovirus infections (Su et al., 2010). 
In addition, pomegranate purified polyphenol extract 
inhibited influenza virus having also a synergistic effect 
with oseltamivir. Influenza virus causes epidemics and 
pandemics in human population. Such virus has several 
zoonite hosts, therefore cannot be eradicated from 
human populations. Influenza continues to be a major 
cause of mortality and morbidity, although the vaccines 
and antiviral therapies (Haidari et al., 2009). These 
authors concluded that punicalagin present in the 
pomegranate extract had virucidal capability and inhibited 
influenza virus RNA proliferation independent on the 
virucidal effect. In addition, the authors also reported the 
synergistic effect of purified polyphenol extract with 
oseltamivir. Such combination and according to the 
authors has advantages because can contribute to a 
potentially greater potency, better clinical efficacy and 
dose-sparing, less toxicity and side effects, and greater 
cost-effectiveness. 
Paracoccidioidomycosis is the most prevalent systemic 
mycosis in Latin America (Coutinho et al., 2002). In the 
absence of drug therapy, the disease is usually fatal. The 
treatment of this mycosis is long (1-2 years) or even 
more. Johann et al. (2010) studying the activity of 
extracts of some plants used in Brazilian traditional 
medicine against the pathogenic fungus that causes this 
mycosis, Paracoccidioides brasiliensis, reported that the 
hexane fraction from stems of P. granatum exhibited 
better antifungal activity against the three clinical isolated 
than other parts of the plant or other fractions of the same 
plant. Nevertheless other extracts of plants revealed to 
be significantly more effective against that fungus than P. 
granatum. 
Candida species are harmless saprophyte yeasts, a 
normal component of the human biota in the 
gastrointestinal tract and oral and vaginal mucosa. They 
can cause superficial infections such as thrush and 
vaginitis. Nevertheless, whether the immune defences of 
the host become compromised, they can cause severe 
systemic infections (Endo et al., 2010). These authors 
reported that punicalagin isolated from pomegranate 
peels possessed strong activity against Candida albicans 
and Candida parapsilosis as well as the combination of 
punicalagin and fluconazole showed a synergistic 
interaction. By transmission electron microscopy, treated 
cells   with   punicalagin   showed  a  thickened  cell  wall, 
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changes in the space between cell wall and the plasma 
membrane, vacuoles, and a reduction in cytoplasmic 
content. Denture stomatitis is commonly associated with 
C. albicans although other Candida species have been 
isolated from lesions. Ethnobotanical studies performed 
in Brazil had demonstrated the utilization of pomegranate 
in oral health (Santos et al., 2009). 
Plasmodium falciparum and Plasmodium vivax are 
endemic in the eastern province of Orissa (India), in 
which malaria constitutes a major health problem for the 
population. Sun-dried rind of the immature fruit of P. 
granatum is presently used as a herbal formulation with 
the name of OMARIA in that province of India, for the 
therapy and prophylaxis of malaria. Dell’Agli et al. (2009) 
studied the in vitro antiplasmodial activityof methanolic 
extracts of a tannin-enriched fraction and of 
compounds/metabolites of the antimalarial plant, to 
estimate the curative efficacy of such extracts and to 
explore the mechanisms of action of the antiplasmodial 
compounds. They conclude that methanolic extracts of 
pomegranate inhibited parasite growth in vitro for D10 
and W2 strains. They also reported that punicalagins, 
punicalins, ellagic acid and its glucosydes were present 
in such extracts, nevertheless the in vivo studies showed 
that the extracts did not present any in vivo efficacy in the 
murine model. The authors suggest that these negative 
results of pomegranate extracts in vivo might be 
attributed to the low bioavailability as well as the kinetic of 
conversion of ellagic acid to inactive metabolites 
urolithins. 
The consumption of pomegranate products leads to a 
significant accumulation of ellagitannins in the large 
intestines, where they interact with complex gut 
microflora (Bialonska et al., 2009a). According to the 
studies performed by these authors the commercial 
extract of pomegranate byproduct provided by POM 
Wonderful (Los Angeles, CA) and punicalagins inhibited 
the growth of pathogenic clostridia and Staphylococcus 
aureus. Nevertheless the probiotic lactobacilli and 
bifidobacteria were not affected by ellagitannins. The 
growth inhibition toward pathogenic bacteria and 
according to the same authors could be attributed to the 
lower media pH due to the presence of punicalagins. 
However, this study was only performed in vitro and the 
authors also refer the importance of phenols metabolism 
that occurs in gut. As reported in the last paragraph, 
punicalagins and ellagic acid are metabolized to urolithins 
by colonic bacteria and the activity may be changed, 
therefore they suggest the need for performing additional 
studies using human fecal microbiota. 
Tayel and El-Tras (2009) demonstrated that methanol, 
ethanol and water extracts of pomegranate peels were 
effective against C. albicans growth. In addition, they also 
proved that pomegranate peel extract aerosol was an 
efficient method for complete sanitizing of semi-closed 
places against C. albicans growth, and thereby could 
contribute for preventing  C. albicans  contamination  and 
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growth in suspected places. 
Two separated works from different authors 
demonstrated the importance of physico-chemical 
properties of pomegranate on the antimicrobial activity. In 
one of them, the authors related such antimicrobial 
activity to the pomegranate antioxidant activity since the 
extent of the inhibitory effects of the pomegranate 
extracts are almost always attributed to their phenolic and 
anthocyanin content of fruits (Duman et al., 2009). These 
authors found that the bioactivity of aril extracts on the 
microorganisms tested (Bacillus megaterium, 
Pseudomonas aeruginosa, S. aureus, Corynebacterium 
xerosis, Micrococcus luteus, Enterococcus faecalis, 
Kluvyeromyces marxianus, Rhodotorula rubra and C. 
albicans) had high total flavonols, phenolics, 
anthocyanins and organic acids. Opara et al. (2009) 
reported that the best activity against S. aureus and P. 
aeruginosa were found in fruit peel fractions, particularly 
from Oman, which was coincident with the highest levels 
of vitamin C detected in these samples. The remaining 
samples were imported. Factors that enhanced the 
amounts of this vitamin in fruit peels also contributed to 
the best antimicrobial activity, and according to the 
authors, sun drying fruit peels induced retention of 
vitamin C and therefore the antimicrobial activity detected 
in the assays. 
Recently, there has been an increasing tendency 
towards the prevention of microbial attack on textiles 
(Han and Yang, 2005). Çali et al. (2009) studied the 
antimicrobial effect of four commercially available dye 
powders obtained from Rubia tinctorum, Allium cepa, 
Mentha sp. and P. granatum on S. aureus ATCC 25923, 
Shigella sonnei RSKK 877, E. coli ATCC 35218, B. 
megaterium RSKK 5117, B. subtilis RSKK 244, B. cereus 
RSKK 863, P. aeruginosa ATCC 29212, Streptococcus 
epidermidis, Salmonella 21.3 and P. aeruginosa 27853. 
The natural dyes with antimicrobial activities found in 
solution were then assayed in textile substrate (wool 
fabric). Maximum inhibition rate obtained against Bacillus 
subtilis of wool samples dyed with P. granatum was 80%. 
These results may suggest that these natural dyes 
possess antimicrobial activity either in solution or in 
substrate. 
 
 
Antioxidant activity 
 
The antioxidant activity was almost determined in vitro 
conditions and several methods could be used for its 
determination. Some works focus on the comparative 
studies of antioxidant activities of diverse fruits and 
vegetables (Stangeland et al., 2009). Generally, 
pomegranate possessed the best antioxidant activity, 
independent on the antioxidant test assayed and 
generally with significant linear correlation between 
phenolics concentration and antioxidant capacity (Elfalleh 
et al., 2009). These authors demonstrated correlation 
coefficients of total  phenols  and  total  flavonoids  to  the 
 
 
 
 
antioxidant activity measured through the ABTS and 
DPPH methods either in peel or juice. 
Pomegranate could be expected be suitable for food 
processing in which thermal devices are used, because 
of their heat resistance. Devatkal et al. (2010) using 
pomegranate rind powders in cooked goat meat patties in 
a hot air oven until the internal temperature reached 80°C 
(approximately 15 min at 170°C) and then packaged in 
low density polyethylene bags and stored at 4°C, for 12 
days obtained good results. With such results, these 
authors consider that this by-product from fruit processing 
may be an economic source of natural antioxidants 
replacing easily the synthetic antioxidants. Without 
cooking, pomegranate rind power revealed also to be 
also a good antioxidant on the preservation of raw ground 
goat meat during refrigerated storage (4°C), aerobically 
packaged in low density polyethylene bags for 6 days, 
even in the presence of salt which generally promotes 
lipid oxidation (Devatkal and Naveena, 2010). 
The effect of cultivars from Iran, Georgia, Turkey and 
Israeli on antioxidant activity also target of study of some 
authors (Borochov-Neori et al., 2009; Mousavinejad et al., 
2009; Pande and Akoh, 2009). All authors reported 
considerable variation in some of the chemical 
composition profile (lipids, phenols, organic acids, 
vitamins, sugars) and antioxidant properties of 
pomegranate samples, independent on the antioxidant 
method performed. Borochov-Neori et al. (2009) also 
described the importance of harvesting season on the 
phenolic content as well as on the antioxidant activity. 
Arils of fruit ripening later in the season contained more 
soluble phenolics and exhibited a higher antioxidant 
activity measured by the ferric reducing ability (FRAP) 
assay. Other authors also reported the diversity of 
antioxidant potency of various cultivars of pomegranate form 
Iran but at the same time they also demonstrated the 
importance of the solvent used for extracting bioactive 
compounds on the degree of antioxidant activity (Sadeghi et 
al., 2009). Several works have demonstrated that peel, 
seeds, juice of pomegranate have antioxidant activity, 
nevertheless, after ingestion those compounds responsible 
for such activity, mainly tannin components, such as 
punicalagins and ellagic acid, are metabolized by gut 
bacteria into urolithins, which readily enter systemic 
circulation. Bialonska et al. (2009b) studied the 
antioxidant activities of seven urolithins derivatives in a 
cell-based assay. They have chosen this method because it 
reflects bioavailability of the test compound to the cells, and 
the antioxidant activity is evaluated in the cellular 
environment and in terms of inhibition of intracellular 
generation of reactive oxygen species. They found that 
urolithins exhibited a significant antioxidant activity 
correlated with the number of hydroxyl groups as well as 
lipophilicity of the molecules. 
 
 
Glucose and lipid metabolism 
 
According to the review article made by Li et al. (2008) P. 
  
 
 
granatum flowers was already prescribed in Unani and 
Ayurvedic medicines for the treatment of diabetes. The 
effect protective of pomegranate flowers’ extracts was 
investigated by some authors on serum lipid profile, 
pancreatic lipid peroxidation and activities of both 
enzymatic and non-enzymatic antioxidant status in 
streptozotocin-induced diabetic rats (Bagri et al., 2009b). 
These authors reported that in these rats, there was an 
increase in blood glucose level, total cholesterol, 
triglycerides, low-density lipoproteins cholesterol, very 
low density lipoproteins, lipid peroxidation level with 
decrease in high density lipoprotein cholesterol, reduced 
glutathione content and antioxidant enzymes namely, 
glutathione peroxidase, glutathione reductase, 
glutathione-S-transferase, superoxide dismutase and 
catalase. The administration of aqueous pomegranate 
flowers’ extracts reversed these parameters, suggesting 
the authors that pomegranate could be used as dietary 
supplement in the treatment and prevention of chronic 
diseases characterised by atherogenic lipoprotein profile, 
aggravated antioxidant status and impaired glucose 
metabolism (Bagri et al., 2009b). 
Based on the fact of pomegranate leaf extracts, 
containing abundant ellagitannins had a potent white fat 
depot-lowering action in obese mice induced by a high-fat 
diet, and also decreased the cellular levels of 
triglycerides by a single orally administered lipid emulsion 
as well as a noticeable activity of modulating lipid 
metabolite of high-lipid rat and inhibiting HMG2CoA 
redutase in vitro, Lan et al. (2009) investigated if 
pomegranate leaf tannins could modulate the lipid 
metabolism and act on liver cells. For this purpose, the 
authors investigated the transport behaviour of ellagic 
acid through HepG2 cell (a kind of liver cellular line) in 
culture with pomegranate leaf tannins, in order to 
evaluate if the possible target of ellagic acid is in cells. At 
the same time, the total cholesterol in the cells was 
tested to find out whether the transportation of ellagic 
acid has an influence on total cholesterol. Their results 
demonstrated for the first time that ellagic acid in 
pomegranate leaf tannins could be transported into the 
cells, which was in correlation with total cholesterol 
alteration in the cells (Lan et al., 2009). 
 
 
Anti-cancer 
 
Singh and Singh (2009) effectuated an ethnobotanical 
study of medicinal plants in Chandauli District, one of the 
less studied regions of India, using semi-structured 
interviews, field observations, preference and direct 
matrix ranking with traditional medicine practitioners. 
They were able to document 40 medicinal plants 
belonging to 27 families. P. granatum was found to be an 
ingredient of a powder along with whole plant of Vernonia 
cinerea Less. (AS38) and leaves of Crataeva nurvala that  
after heated with castor and coconut oils was used in  the 
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external treatment of breast cancer. 
In addition to that ethnobotanical study in India, 
pomegranate has been target of studies in laboratories 
and cancer centres that have showed its properties 
against diverse types of cancers. Two recent review 
articles reported the laboratory and clinical evidence of 
cancer chemoprevention or treatment of pomegranate 
(Adhami et al., 2009: Amin et al., 2009). Amin et al. 
(2009) reported that pomegranate fruit, pomegranate 
juice, pomegranate seed and seed oil act in prostate, 
breast, skin, colon, lung, oral and leukaemia cancers, 
through antioxidant, antiproliferation (growth inhibition, 
cell cycle disruption and apoptosis), antiangiogenisis and 
anti-inflammatory mechanisms of action. Ellagic acid, one 
of the constituents of pomegranate juice and seed oils 
are reported as acting against cancer of skin, pancreas, 
breast, prostate, colon, intestine, oesophagus, bladder, 
oral, leukaemia, liver and neuroblastoma, which 
mechanisms of action are similar to those described for 
pomegranate. Ellagic acid acts synergistically with 
cisplatin, vinorelbine, quercetin, resveratrol, cyclosporine 
A, 6-gingerol and selenomethionine. The same authors 
gave information about ongoing clinical trials with natural 
compounds, including pomegranate, in several parts of 
the world. Either for prostate therapy or prevention, the 
several sites reported (M.D. Anderson Cancer Center; 
University of California, Los Angeles; Radiant Research; 
Roll International Corporation; Jonsson Comprehensive 
Cancer Center; University of California, Irvine; and 
University of Oslo) are in the great majority in the status 
of recruiting and/or phases I-III trials (Amin et al., 2009). 
The other review article Adhami et al. (2009) focused on 
the effects of pomegranate fruit on diverse types of 
cancer (breast, prostate, lung, colon, and skin) as well as 
the mechanisms involved. They also reported that 
extracts of pomegranate or the juice are generally more 
active than individual or purified compounds. They 
suggest the existence of a synergistically effect of all 
compounds present in extracts, explaining therefore the 
inhibition of multiple targets observed in many studies. 
After ingestion, polyphenols present in pomegranate 
are metabolised. Ellagitannins are transformed by human 
colon flora into urolithins. In a mouse model, these 
metabolites preferentially accumulate in prostate, colon, 
and intestinal tissues. Compounds inhibiting the 
cytochrome P450 enzyme, CYP1B1, activity seem to 
exert beneficial effects at three stages of prostate cancer 
development. In a recombinant CYP1B1-mediated 
ethoxyresorufin-O-deethylase (EROD) assay, 
pomegranate ellagitannins/microbial metabolites were 
examined for their CYP1B1 inhibitory activity. Urolithins, 
punicalins and punicalagins were also tested for their 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced 
CYP1B1 inhibitory activity in the 22Rv1 prostate cancer 
cell line. Urolithins were also studied for their cellular 
uptake and inhibition of TCDD-induced CYP1B1 
expression (Kasimetty et al., 2009).  After  these  studies, 
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the authors concluded that are effective inhibitors of 
CYP1B1 enzyme activity and expression. 
Concerning breast cancer, Sturgeon and Ronnenberg 
(2010) described the in vitro cell culture studies, animal 
studies and available data about the property of 
pomegranate to prevent breast cancer as well as the 
possible mechanisms involved. Epidemiological studies 
have demonstrated that elevated serum levels of the 
estrogens estrone and estradiol and lower levels of sex-
hormone binding globulin, after menopause substantially 
increased the risk of breast cancer. After menopause, 
most circulating estrogen is derived from the conversion 
of adrenal androgens to estrone by aromatase in adipose 
tissue. Some of estrone is further converted to estradiol, 
which is the most biologically active estrogen in breast 
tissue. The authors reported that fermented pomegranate 
juice had higher aromatase inhibitory activity than 
unfermented polyphenols extracted from pomegranate 
peels, maybe due to breakage of flavonoid-sugar 
complexes during fermentation. Cyclooxigenase inhibition 
by the constituents of the pomegranate fruit, seed oils or 
pure compounds (ellagic acids and anthocyanins) induce 
the decrease of prostaglandin E2 (PGE2) that has been 
shown to downregulate aromatase expression. Ellagic 
acid seems to exhibit apoptosis, inhibits activation of 
inflammatory pathways, and inhibits angiogenesis. In 
addition to aromatase that converts adrenal androgens to 
estrone, there is 17β-hydroxysteroid dehydrogenase that 
converts estrone to estradiol. several fractions of 
pomegranate juice was demonstrated to inhibit this 
enzyme or have antiestrogenic activity. These assays 
being performed in animal models need to be confirmed 
in humans (Sturgeon and Ronnenberg, 2010). 
Some authors found that punicic acid inhibited the 
proliferation of estrogen insensitive breast cancer cell line 
(MDA-MB-231) and an estrogen sensitive cell line 
developed from the MDA-MB-231 cells (MDA-ERα7), as 
well as induced apoptosis in both type of cells. Such 
inhibition of proliferation was due to lipid peroxidation of 
cells and activation of protein kinase C (PKC) 
(Grossmann et al., 2010). Tran et al. (2010) revealed that 
punicic acid and α-eleostearic acid present in seed oil of 
pomegranate inhibited the estrogen receptors ERα and 
ERβ depending on the dose. For example, lower doses of 
punicic acid acted as agonist for both receptors and 
antagonist at higher concentrations. α-Eleostearic acid 
acted as antagonist only against ERα and ERβ at higher 
concentrations of those for punicic acid. Both acids were 
effective in producing effective inhibition of cancer cell 
proliferation: MCF-7 (ER-positive human breast cancer 
cells) and MDA-MB-231 (ER-negative human breast 
cancer cells). The same work also demonstrated that 
those two acids promote ER mRNA expression in a 
manner analogous to that produced by estradiol for both 
ERα and ERβ only in MCF-cells. Both acids are Selective 
Estrogen Receptor modulator (SERM) (Tran et al., 2010). 
In   a  short  communication,  Khan  (2009)  compiled  the 
 
 
 
 
studies about the role of pomegranate in colon cancer 
and according to their compilation, pomegranate fruit was 
described as being able to reduce the number of aberrant 
cyptic foci (ACF) of the colon in male F-344 rats before 
and after treatment with colon-specific chemical 
carcinogen, azoxymethane; and to increase the hepatic 
glutathione S transferase (GST) activity in rats. 
Pomegranate seed oil was also capable to reduce the 
incidence of colonic cancer in rats. Punicalagin, ellagic 
acid and total pomegranate tannin inhibited the 
proliferation of colon cancer cell (SW480, HT29, HCT116, 
SW620). Mechanistically, punicalagin and ellagic acid 
induce apoptosis of colon cancer cells, inducing caspase 
9 and procaspase 3, member of caspase family of 
proteases. The author also referred that pomegranate 
juice, punicalagin and total pomegranate tannin 
suppressed tumour necrosis factor-alpha (TNFα) and 
COX-2 in animal and in vitro models. Pomegranate juice 
also inhibited phosphorilation of nuclear factor-kB (NF-
kB). DNA binding of this transcription factor was 
suppressed only by punicalagin (Khan, 2009). 
A set of cellular signals critical for the development and 
homeostasis of multicellular animals are those elicited by 
Wnt proteins. In the canonical Wnt pathway, the signal 
produced by the binding of Wnt ligands to cell surface 
receptors is transmitted through a cytoplasmic protein 
called disheveled (Dvl) to inhibit the activity of a complex 
of cellular proteins that phosphorylate another protein, -
catenin, and target it for destruction. Therefore, Dvl-
mediated inhibition of the -catenin destruction complex 
results in increased levels of cellular -catenin and 
translocation of -catenin into the nucleus. In this place, 
-catenin activates transcription factors of the LEF/TCF 
families and initiates transcription of a spectrum of target 
genes that affect tissue proliferation, differentiation, and 
tumorigenesis. In colon cancer, a large percentage of the 
tumour arises from activating mutations in the Wnt 
pathway (Sharma et al., 2010). Sharma et al. (2010) 
studied the effects of urolitinins, ellagic acid and 
ellagitannin-rich fruit extracts on Wnt signalling in a 
human 293T cell line using a luciferase reporter of 
canonical Wnt pathway-mediated transcriptional 
activation. After this study, they concluded that urolithins 
produced in the colon from ellagitannins present in 
pomegranate are inhibitors of the canonical Wnt 
signalling pathway at physiologically relevant 
concentrations. Thus and according to the authors, the 
colon is not a excretory organ, but also an active place 
for the production of physiologically relevant metabolites 
through microbiota transformation of dietary components. 
 
 
Anti-inflammatory activity 
 
The NO production induced by lipopolyssacharide (LPS) 
in RAW 264.7 macrophage cells was inhibited by 
pomegranate aqueous extracts. The extracts used and in  
  
 
 
the concentrations tested did not present any cytotoxicity 
(Kumar-Roiné et al., 2009). Lee et al. (2010) also 
demonstrated the capacity of pomegranate extracts for 
inhibiting NO production by RAW 264.7 macrophage 
cells. But in addition, they also find that pomegranate 
(100 mg/Kg) significantly decreased carrageenan-
induced mice paw oedema for several hours (5 h at the 
maximum). At the same time, the authors using a column 
chromatography combined with in vitro bioassay-guided 
fractionation found that punicalagin, punicalin, strictinin A, 
and granatin B were able to inhibit NO production as well  
as iNOS expression in RAW 264.7 cells. Granatin B was 
that showed the strongest iNOS and COX-2 inhibitory 
effects, and exhibited these effects in the inhibition of 
paw swelling and PGE2 level in carrageenan-induced 
mice. According to these results, the authors proposed 
that granatin B could be used as a standard marker for 
the anti-inflammatory effect of pomegranate (Lee et al., 
2010). 
Mast cells derived mediators induce oedema, destroy 
connective tissue, and are involved in lymphocyte 
chemotaxis and infiltration and in pathological fibrosis in 
rheumatoid arthritis joints. Activation of the myeloid 
precursor cell line KU8I2 results in the degranulation 
accompanied by the production of chemical mediators 
such as histamine, proteases, metabolites of arachidonic 
acid and several inflammatory and chemotactic cytokines 
including IL-6 and IL-8. Such cells are suitable models for 
studying the activation of degranulation of human mast 
cells (Rasheed et al., 2009). These authors using KU8I2 
cells stimulated with phorbol-12-myristate-13-acetate 
(PMA) plus calcium ionophore A23I87 (PMACl) studied 
the inhibitory effect of polyphenol-rich pomegranate fruit 
extract on pro-inflammatory cytokine gene expression 
and production by quantitative real time-PCR, and 
cytokine-specific ELISA assays. The effect of polyphenol-
rich pomegranate fruit extract on the activation of 
mitogen-activated protein kinases (MAPKs) and the NF-
kB in PMACl stimulated KU8I2 cells. They found that 
polyphenol-rich pomegranate fruit extract decreased 
PMACl stimulated inflammatory gene expression and 
production of IL-6 and IL-8 in KU8I2 cells. The inhibitory 
effect of the extract on the pro-inflammatory cytokines 
was MAPK subgroups c-jun N-terminal kinase (JNK- and 
extracellular-regulated kinase (ERK) dependent. The 
extract also inhibited NF-kB by inhibiting IkB-degradation 
in human basophil cells. The results obtained by the 
authors suggest that polyphenol-rich pomegranate fruit 
extract exerts its inhibitory effect on IL-6 and IL-8 
expression via modulation of the activation and DNA 
binding activity of NF-kB (Rasheed et al., 2009). 
Orissa Malaria Research Indigenous Attempt 
(OMARIA) in Orissa, India, used herbal formulation 
containing the sun-dried rind of the immature fruit of 
pomegranate for the therapy and prophylaxis of malaria. 
A complication of the infection by P. falciparum is an 
inflammatory cytokine-driven  disease  associated  to  an 
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up-regulation and activity of metalloproteinase-9 (MMP-9) 
and to the increase of TNF production. Dell’Agli et al. 
(2010) used a fraction enriched in tannins obtained from 
the methanolic extract of the fruit rind as well as ellagic 
acid, punicalagin and urolithin metabolites for evaluating 
its capacity to inhibit the secretion of MMP-9 induced by 
P. falciparum haemozin or TNF in human THP-1 
monocytic leukaemia cells. Extract, pure compounds and 
urolithins inhibited the secretion of MMP-9 induced by 
haemozin or TNF at transcriptional level due to the lower 
levels of MMP-9 mRNA. The fraction enriched in tannins 
and pure compounds also inhibited MMP-9 promoter 
activity and NF-kB driven transcription. In addition to the 
anti-malarial activity of fruit rind of pomegranate, it can 
also act in the inhibition of the pro-inflammatory 
mechanisms involved in the onset of cerebral malaria 
(Dell’Agli et al., 2010). 
 
 
Other biological activities 
 
In addition to the biological activities of pomegranate 
reported so far in the present work, others were also 
found during our database research. They include for 
example, the reversible inhibition of human plasma 
thrombin at physiological pH values by the pomegranate 
extracts (endocarp and mesocarp) which were mainly 
constituted by catechin along with gallic acid, epicatechin 
and ellagic acid (Cuccioloni et al., 2009). The hyperbolic 
nature of the inhibition curves also revealed that the 
polyphenol-thrombin complex behaves as a non-
cooperative reversible system. The authors also 
suggested a moderate-affinity binding site on the enzyme 
for the pomegranate polyphenols (Cuccioloni et al., 
2009). 
The effect of pomegranate juice and the polyphenol-
rich extracts from pomegranate fruit on platelet 
aggregation, calcium mobilisation production of 
thromboxan A2 induced by collagen and arachidonic acid 
revealed that both types of samples were able to reduce 
all platelet responses studied; polyphenol-rich extracts 
from pomegranate fruits showed a strong action in 
reducing platelet activation, being active at 
concentrations similar to those after ingested (Mattiello et 
al., 2009). The results obtained by these authors 
demonstrated that the cardiovascular health benefits of 
pomegranate may in part be related to the ability of 
polyphenols to inhibit platelet function. Other study using 
isoproterenol that induces cardiac necrosis in rats 
demonstrated for the first time that a pre-supplementation 
with pomegranate juice for 30 consecutive days before 
administration of isoproterenol on days 29 and 30th 
showed lesser increase in heart weight, infarct size, 
plasma marker enzymes, lipid peroxidation, Ca2+ ATPase 
and a significant protective effect in endogenous 
enzymatic and non-enzymatic antioxidants when 
compared    to    those    animals     only     treated     with 
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isoproterenol (Jadeja et al., 2010). 
Afaq et al. (2009), using pre-treatment of human 
reconstituted skin (EpiDermTM FT-200) with 
pomegranate-derived products found an inhibition of 
UVB-induced CPD and 8-OHdG as well as protein 
oxidation and PCNA protein expression. They also 
reported an inhibition of UVB-induced MMPs 
(collagenase, gelatinase, stromelysin, marilysin, elastase 
and tropoelastin) in pretreated of epiderm with 
pomegranate-derived products. They also described a 
decrease of in UVB-induced protein expression of c-Fos 
and phosphorylation of c-Jun. Thus, the authors 
considered that all pomegranate-derived products (juice, 
extract and oil) may be useful against damages in skin 
induced by the exposition to UVB (Afaq et al., 2009). 
Some authors demonstrated that pomegranate juice 
prevented the negative effects of iodoacetate (used for 
inducing osteoarthritis) in mice. At the highest 
concentration tested (20 ml/Kg of juice), chondrocyte 
organization was preserved by approximately 50%, and 
the number of cells was locally increased with less 
damage to proteoglycan in the epiphyseal plate over a 
period of 2 weeks. No inflammation cells or cell 
proliferation was in the synovial fluid were observed in all 
groups of treated-mice (Hadipour-Jahromy and Mozaffari-
Kermani, 2010). 
Ulcerative colite induced in mice by dextran sulphate 
sodium ameliorated after treatment with flower 
pomegranate extract and its ellagic acid rich fraction. The 
colonic inflammation was significantly attenuated as well 
as histamine, myeloperoxidase and oxidative stress 
(Singh et al., 2009). 
Pomegranate and more 5 plants are used in Algerian 
Sahara traditional pharmacopoeia for inhibiting the 
calcium crystallization and therefore to prevent 
urolithiasis, being calcium oxalate one of the main 
constituents of urinary stones. Sekkoum et al. (2010) 
studied the effect of the extracts of plants, including from 
pomegranate, on the kinetics of oxalate crystallization 
made in vitro. The aqueous extract of pomegranate under 
the concentration of 1 mg/ml, exerted an inhibitory effect 
on crystalline aggregation but does not influenced the 
crystalline growth. Abbasi et al. (2009) reported 30 plants 
species used in remote zones of Pakistan for the 
treatment of jaundice and hepatitis, after compiling 95 
responses to questionnaires. In the same work, the 
authors reported the chemical constituents of such plants 
compiled from relevant sources. Fruits and seeds of 
pomegranate were reported in this work as used for the 
treatment of jaundice and hepatitis. Dried fruits and 
seeds must be grounded and taken together with sugar 
thrice a day for three weeks after dissolution of three 
teaspoons in one cup of water. Other way to 
administered this remedy reported by the authors 
consisted in two teaspoons of dried rind powder mixed 
with sugar and taken orally along with water at morning 
for a week. 
 
 
 
 
The hepatopreventive capacity of pomegranate 
beverage (flowers) was evaluated by Celik et al. (2009) in 
rats exposed to trichloroacetic acid (TCA). This ability 
was evaluated by measuring level of serum enzymes, 
antioxidant defence systems and lipid peroxidation 
content in several organs of rats. The rats submitted to 
TCA and pomegranate samples showed lower levels of 
alanine aminotransferase (ALT), aspartate 
aminotransferase (AST), LDH, creatine kinase (CK), 
malonaldehyde content in liver, brain, kidney and hearth 
tissues. An increase of the activity of GST in liver, brain 
and spleen was observed. Pomegranate as 
immunosuppressive agent was also reported by 
Amirghofran (2010) in traditional Iranian medicine. 
 
 
CONCLUSION 
 
The pomegranate has been an inexhaustible source of 
research going from chemistry in the search for new 
compounds, techniques of production and conservation, 
biotechnology in search of more profitable varieties, to 
the biological effects as anti-microbial antioxidant, anti-
inflammatory, anticancer, anti-diabetic, among other 
applications. However, many biological studies that are 
described are still performed in vitro or in animals whose 
metabolic pathways are not exactly the same that those 
occurring in humans. However, clinical trials are in 
progress exploring the beneficial effects of pomegranate 
extracts. Several fields of application of pomegranate 
along with other species have been patented in these last 
two years, showing therefore the importance of such 
plant: skin care (Gross and Gross, 2009); for preventing 
skin dryness and skin aging (Cho et al., 2010); for 
preventing and/or inhibiting the effect of psychoemotional 
stress on the hair (Briese et al., 2010); for improving the 
appearance of the skin (Jacobs, 2010); for improving and 
retaining the moisture level in the skin (Vilinsky, 2010); 
for waist and tummy firming (Khan and Zaidi, 2009); for 
treating alopecia through external application (Jo et al., 
2009); to prevent dental diseases e.g. plaque (Babu et 
al., 2009); for treating sickle cell disease (Desai and 
Desai, 2009; Desai, 2010); among other patents not 
referred in the present work. 
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